{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"029-740-168-108-952","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"029-740-168-108-952","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11882,"type":"PATENT","title":"Yeshiva University Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":2927,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8485,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:Yeshiva Univ*. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1369
Search Applicants and Owners separately:Yeshiva Univ*. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1369
(a) comprises a deletion or point mutation of the leuD gene,
(b) is auxotrophic for leucine as a result of a deletion mutation of the leuD gene generated by allelic exchange, or
(c) is formulated with a carrier that renders the M. tuberculosis more immunogenic."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1 , wherein the M. tuberculosis comprises a deletion or point mutation of the leuD gene."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1 , wherein the M. tuberculosis is auxotrophic for leucine as a result of a deletion mutation of the leuD gene generated by allelic exchange."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1 , wherein the M. tuberculosis is formulated with a carrier that renders the M. tuberculosis more immunogenic."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["A method for inducing immunity to M. tuberculosis in a subject, the method comprising administering to the subject a recombinant M. tuberculosis that is auxotrophic for leucine, wherein the M. tuberculosis either comprises a deletion or point mutation of the leuD gene or is auxotrophic for leucine as a result of a deletion mutation of the leuD gene generated by allelic exchange."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5 , wherein the M. tuberculosis comprises a deletion or point mutation of the leuD gene."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5 , wherein the M. tuberculosis is auxotrophic for leucine as a result of a deletion mutation of the leuD gene generated by allelic exchange."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5 , wherein the recombinant M. tuberculosis is formulated in a carrier that renders the recombinant M. tuberculosis more immunogenic."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5 , wherein the recombinant M. tuberculosis is administered in conjunction with a suitable pharmaceutical carrier."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5 , wherein the recombinant M. tuberculosis is administered to the subject by injection."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 2 , wherein the recombinant M. tuberculosis is formulated in a carrier that renders the recombinant M. tuberculosis more immunogenic."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 2 , wherein the recombinant M. tuberculosis is administered in conjunction with a suitable pharmaceutical carrier."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 2 , wherein the recombinant M. tuberculosis is administered to the subject by injection."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6 , wherein the recombinant M. tuberculosis is formulated in a carrier that renders the recombinant M. tuberculosis more immunogenic."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6 , wherein the recombinant M. tuberculosis is administered in conjunction with a suitable pharmaceutical carrier."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6 , wherein the recombinant M. tuberculosis is administered to the subject by injection."],"number":16,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}